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A series of five adducts of m-ethylphenylxanthate of nickel(II) [(m-C2H5C6H4OCS2)2Ni] with nitrogen donors have been 
synthesized in 1:2 molar ratio by the reaction of aqueous solution of NiCl2.6H2O with aqueous solution of sodium salt of 
m-ethylphenylxanthate. These metal complexes are reacted with nitrogen donors to give donor stabilized complex,
[(m-C2H5C6H4OCS2)2(L)2Ni] where, L= 2-, 3-, 4-ethylpyridine and 2-, 3-chloropyridine. The adducts have been
characterized by elemental analysis, molar conductance and magnetic susceptibility measurements, IR, electronic, mass
spectral studies, thermogravimetric analysis, powder X-ray diffraction, biological studies. The spectral studies have revealed
the octahedral coordination of ligands around Ni(II) metal ion. The adducts are found to be paramagnetic and non-ionic in
nature. Mass studies show the monomeric nature of the adducts. The complexes have depicted potential antifungal activity
against Bipolaris maydis and Rhizoctonia solani. Some of the synthesized Ni(II) xanthate complexes display in vitro
cytotoxic efficacy against human cancer cell lines.
Keywords: m-Ethylphenylxanthate, Monomeric, Paramagnetic, Pyridine, Thermogravimetric analysis 
Xanthates are the ligands containing sulphur and 
oxygen, which gives diverse and abundant 
coordination complexes with transition and main 
group metals.
1 
These are known as dithiocarbonates. 
The chemistry of transition metal xanthates holds 
much attention due to their importance in the field of 
metalloenzymes, material precursors, metallurgy and 
catalysts.
2-4
 Metal xanthates are extensively used as 
fungicides, pesticides, rubber accelerators, corrosion 
inhibitors, reagents in agriculture and for treating HIV 
infections.
5-9
. Xanthates are much efficient for 
removing heavy metals from waste water due to 
their low solubility products and high stability 
constants
10
. Xanthates inhibit the replication of both 
DNA and RNA viruses in vitro and therefore, possess 
enhanced antiviral and antitumor activity
11,12
. The 
discovery of urease (a nickel containing enzyme) has 
expanded the significance of nickel in bioinorganic 
chemistry
13
. Nickel is an essential cofactor of 
enzymes found in eubacteria, archaebacteria, fungi 
and plants 
14-16
. These enzymes catalyse many redox 
and non- redox reactions in the living organisms 
17
. 
Nickel(II) complexes are the most promising 
anticancer drugs in comparison to the traditional 
cisplatin
18-20
. The present investigation reported the 
synthesis and characterization of adducts of m-
ethylphenylxanthates of nickel(II) with nitrogen 
donors (substituted pyridines) by various physico-
chemical techniques and their biological importance. 
Materials and Methods 
Toluene and n-hexane were freshly dried over 
sodium wire. Dichloromethane and methanol were 
dried over P2O5 and CaCO3, respectively. m-
ethylphenol was purified by distillation before use. 
Carbon, hydrogen, nitrogen and sulphur analysis was 
carried out on elemental analyzer (CHNS-932, LECO 
Corporation, USA). Molar conductance was measured 
in DMF (10
−3
M) at room temperature using a 
digital conductivity meter “Century CC 601” and a 
conductivity cell with cell constant 1. Magnetic 
susceptibility of adducts was recorded at room 
temperature by VSM method. Infrared (IR) spectra of 
adducts over the region 4000-400 cm
−1
 was recorded 
on “Perkin Elmer FTIR spectrophotometer” 
using KBr pellet. Systronics 119 UV-visible 
spectrophotometer was used to record electronic 
spectra in the range of 12500-40000 cm
−1
 and ESI-




MS spectrophotometer was used to record mass 
spectra of the compounds. Thermogravimetric 
analysis (TGA/DTA) of complexes was recorded on 
Linseis STA-PT-thermoanalyzer. Powder X-ray 
diffraction (XRD) was done on diffractometer system 
XPERT-PRO. FESEM was carried out at different 
magnifications on Hitachi-PU 5.0 kV LA30(UL). The 
antifungal activity of complexes was performed using 
Poisoned Food Technique and in vitro anticancer 
activity was tested using Sulphorhodamine Blue 
(SRB) assay  
 
Preparation of sodium salt of m-ethylphenylxanthate 
Sodium salt of dithiocarbonate was prepared using 
standard protocol
21
. Sodium metal (0.74 g, 0.26 mol) 
was added to a toluene solution of freshly distilled m-
ethylphenol (31.6 mL, 0.26 mol). The contents were 
refluxed for three hours till white precipitates started 
appearing. When sodium metal was completely 
dissolved, CS2 (1.95 mL, 0.26 mol) was added 
subsequently to the reaction mixture at 15 °C and 
stirred for 3 h. The compound was isolated by 
filtration using alkoxy funnel fitted with G-4 sintered 
disc and dried under reduced pressure in a vacuum 
pump that lead the formation of m-C2H5C6H4OCS2Na 
as pale yellow solid. 
 
Preparation of Bis(m-ethylphenylxanthato)nickel(II) complex 
The aqueous solutions of sodium salt of m-
ethylphenylxanthate (4.4 g, 0.02 mol) and NiCl2.6H2O 
(2.37 g, 0.01 mol) were mixed when green coloured 
precipitates appeared, which were filtered using 
alkoxy funnel and dried under reduced pressure in a 
vacuum pump. 
 
Preparation of 1:2 adducts with nitrogen donors 
 
(a) Bis(m-ethylphenylxanthato)bis(2-ethylpyridine)nickel(II) 
A weighed amount of [(m-C2H5C6H4OCS2)2Ni] 
(1.18 g, 0.0026 mol) was dissolved in 
dichloromethane and to this a dichloromethane 
solution of 2-ethylpyridine (0.59 mL, 0.0052 mol) 
was added with constant stirring at room temperature. 
After stirring for 3-4 h, the reaction mixture was 
refluxed for 15 min for the sake of completion  
of reaction. The excess of dichloromethane was 
evaporated in vacuum that lead the formation of the 




The adduct was prepared by the same procedure as 
described above in (a), but instead of 2-ethylpyridine, 
3-ethylpyridine (0.59 mL, 0.0052 mol) was added.  
The compound was found to be [(m-C2H5 




The adduct was prepared in the same manner as 
described above, but in this case, 4-ethylpyridine 
(0.59 mL, 0.0052 mol) was added to the 
dichloromethane solution of bis(m-
ethylphenyldithiocarbonato)nickel(II) with constant 
stirring at room temperature and then refluxing for  
15 min to complete the reaction. Excess of the solvent 
was evaporated in vacuum, which gives green 
coloured adduct. The composition of the adduct was 




A weighed amount of [(m-C2H5C6H4OCS2)2Ni] 
(1.18 g, 0.0026 mol) was dissolved in 
dichloromethane and to this a dichloromethane 
solution of 2-chloropyridine (0.49 ml, 0.0052 mol) 
was added with constant stirring at room temperature. 
After stirring for 3-4 h, the reaction mixture was 
refluxed for 15 min for the sake of completion of 
reaction. The excess of dichloromethane was 
evaporated in vacuum, that results in the formation of 
the adduct [(m-C2H5C6H4OCS2)2(C5H4NCl)2Ni] as 
dark green solid. 
 
(e) Bis(m-ethylphenylxanthato)bis(3-chloropyridine)nickel(II) 
The adduct was prepared in the same manner  
as described above in (d), but instead of  
2-chloropyridine, 3-chloropyridine was added  
to the dichloromethane solution of bis(m-
ethylphenylxanthate)nickel(II) with constant stirring 
at room temperature and then refluxing for 15 min to 
complete the reaction. Green coloured adduct was 
obtained and the composition was found to be [(m-





Potato dextrose agar (PDA) medium was prepared 
in a flask and sterilised. The test solutions were 
prepared by dissolving the compounds in DMSO. The 
test solutions were mixed in the nutrient medium 
(PDA) and then discharged in the petridishes inside 
the laminar flow. After solidification, the petridishes 
were inoculated (using a cork borer) with 7 days  
old culture of the fungus Bipolaris maydis and 




Rhizoctonia solani, separately by placing 2 mm bit in 
the center of the petridishes. The petridishes were 
incubated at 27 °C for 4 days. The radial growth of 
fungus determines the efficiency of each test sample. 
The linear fungal growth in controlled manner was 
measured at various concentrations of the test sample. 
The percent inhibition of the fungus over control was 
calculated as: 
% Inhibition (I) = ((C – T)/C) × 100,  
where C is the diameter of the fungus colony in the 
control plate after 4 days and T is the diameter of the 
fungus colony in the tested plate after 4 days. 
 
Cytotoxic studies 
The complexes were subjected to in vitro 
anticancer activity against various human cancer cell 
lines (Monks et al.)
22
. In brief, the cells were grown in 
tissue culture flasks in growth medium at 37 °C in an 
atmosphere of 5% CO2 and 90% relative humidity in 
a CO2 incubator (Hera Cell, Heraeus; Asheville, NCI, 
USA). The cells at sub-confluent stage were harvested 
from the flask by treatment with trypsin (0.05% 
trypsin in PBS containing 0.02% EDTA) and 
suspended in growth medium. Cells with more than 
97% viability (trypan blue exclusion) were used for 
determination of cytotoxicity. An aliquot of 100 μl of 
cells (10
5
 cells/mL) was transferred to a well of 96-well 
tissue culture plate. The cells were allowed to grow 
for 24 h. Extracts (100 μL/well) were then added to 
the wells and cells were further allowed to grow for 
another 48 h.The anti-proliferative SRB assay which 
estimates cell number indirectly by staining total 
cellular protein with the dye SRB was performed to 
assess growth inhibition. The SRB staining method is 
simpler, faster and provides better linearity with cell 
number. It is less sensitive to environmental 
fluctuations and does not require a time sensitive 
measurement of initial reaction velocity (Skehan  
et al.
23
). The cell growth was stopped by gently 
layering 50 μl of 50% (ice cold) trichloroacetic acid 
on the top of growth medium in all the wells. The 
plates were incubated at 4 °C for 1 h to fix the cells 
attached to the bottom of the wells. Liquid of all the 
wells was then gently pipetted out and discarded. The 
plates were washed five-times with distilled water and 
air-dried. SRB 100 μL (0.4% in 1% acetic acid) was 
added to each well and the plates were incubated at 
room temperature for 30 min. The unbound SRB was 
quickly removed by washing the cells five-times  
with 1% acetic acid. Plates were air-dried, tris buffer 
(100 μL, 0.01 M, pH 10.5) was added to all the wells 
to solubilize the dye and then plates were gently 
stirred for 5 min on a mechanical stirrer. The optical 
density (OD) was recorded on ELISA reader at  
540 nm. The growth inhibition of 50% or above was 
considered active while testing compounds.  
 
Results and Discussion 
The addition complexes of bis(m-
ethylphenylxanthato)nickel(II) with nitrogen donors 
were found microcrystalline solids, green to dark 
green in colour. These complexes were found soluble 
in dimethylformamide and dimethylsulfoxide, 
partially soluble in chloroform, insoluble in acetone, 
benzene, carbontetrachloride, and water. The yield of 
adducts and percentage of nickel is given in Table 1. 
On the basis of elemental analysis (Table 2), the 
adducts have been assigned the general formula [(m-
C6H4C2H5OCS2)2(L)2Ni], L= 2-, 3-, 4-ethylpyridine or 
2-, 3-chloropyridine. 
 
Molar conductance and magnetic susceptibility measurements 
Molar conductance values of the millimolar 







 (Table 2). The values 
were much smaller than that expected for any uni-
univalent electrolyte suggesting that these complexes 
were neutral and non-ionic in nature
24,25
. The 
magnetic moment values of these adducts were found 
in the range of 2.87-3.30 B.M., that are in good 
agreement with the values observed for octahedral 
nickel(II) complexes. The magnetic moment values 
suggested the paramagnetic nature of complexes and 
the absence of direct magnetic exchange between 
nickel(II) ions
26
 (Table 2). 
 
Table 1 — Adducts of bis(m-ethylphenylxanthato)nickel(II) along with yield and percentage of metal 
































The IR spectrum of Bis(m-ethylphenylxanthato) 
bis(2-chloropyridine)nickel(II) is shown in Fig. 1.  
It exhibits absorption bands for xanthate ligands at 
1270-1210 cm
−1
 and 1140 cm
−1
 which are assigned to 
νas(C-O-C) and νs(C-O-C) vibrations while the bands 
at 1030-1040 cm
−1
 and 614-644 cm
−1
 belongs to the 
v(C-S) vibrations
27,28
. Presently, there is an intense 
band corresponding to ν(C-S) vibrations in the  
range 1014-1062 cm
−1
 observed for all the adducts 
which suggested xanthate as a symmetrical bidentate 
chelating ligand
29,30
. The characteristic bands 
corresponding to νas(C-O-C) and νs(C-O-C) vibrations 





, respectively. In all the complexes, 
the bands occurring below 400 cm
−1
 have been 
assigned to ν(Ni-S) stretching modes
31,32
 (Table 3).  
In free bases, the characteristic bands corresponding 
to C-N stretching vibrations were observed in the 
region 1440-1460 cm
−1
. However, on coordination 
with metal ion, these bands undergo blue shift and 
new bands appeared in the region 1480-1495 cm
−1
. 
The blue shift is due to back-bonding from metal to 
the ring through extensive π-bonding. This clearly 
established the coordination of substituted pyridines 
with nickel(II) ion through ring nitrogen atom. In the 
Table 2 — Molar conductance, magnetic moments and analytical data of 1:2 adducts of bis(m-ethylphenylxanthato)nickel(II) with 
substituted pyridines 




Percentage (%) found 
(calculated) 

















































































Fig. 1 — IR spectrum of Bis(m-ethylphenylxanthato)bis(2-chloropyridine)nickel(II) 
 




adducts of bis(m-ethylphenylxanthato)nickel(II) with 
chloropyridines, a strong band due to C-Cl stretching 





The electronic spectra of 1:2 adducts of bis 
(m-ethylphenylxanthato)nickel(II) with substituted 





 and 24875-26960 cm
−1
 













T1g(P)(v3), respectively (Table 4). The electronic 
spectra spectra of Bis(m-ethylphenylxanthato)bis(3-
ethylpyridine)nickel(II) is shown in Fig. 2. The 
appearance of these bands along with shoulders 
revealed that the adducts synthesized have distorted 
octahedral geometry around Ni(II) metal ion
33,34
. In 
addition to these low intensity bands, M → L charge 






The mass spectrum of the adduct [Ni(m-
C2H5C6H4OCS2)2 (3-ethylpyridine)2] (m/z =666.6) 
showed a weak molecular ion peak at m/z 666 and a 
base peak at 452.6, which was highly intense and 
corresponds to a fragment [Ni(S2COC6H4C2H5)2]
+
. 
The mass spectra of [Ni(m-C2H5C6H4OCS2)2(2-
chloropyridine)2] showed a weak molecular ion peak 
at m/z 679.6 and a high intensity base peak at m/z 
452.2 which corresponds to a stable fragment 
[Ni(S2COC6H4C2H5)2]
+
 (Fig. 3). Besides these two 
peaks, many other peaks were observed with different 
m/z values in the mass spectra of the complexes. The 
occurrence of molecular ion peak at this value 
indicated the monomeric nature of the adducts. The 
elemental analysis values agreed well with the values 
calculated from the molecular formulae assigned to 




The complexes were subjected to thermo-
gravimetric analysis from 30-1000 °C in nitrogen 
atmosphere. The TG curve of the adduct [Ni(m-
C6H4C2H5OCS2)2(2-ethylpyridine)2] showed an initial 
loss in weight of 20% at 289.3 °C (calculated= 16%) 
due to loss of one molecule of 2-ethylpyridine. 
Another loss of pyridine molecule was observed  
Table 3 — Infrared spectral data of 1:2 adducts of bis(m-ethylphenylxanthato)nickel(II) with substituted pyridines 




































































Table 4 — Electronic spectral data of 1:2 adducts of bis(m-ethylphenylxanthato)nickel(II) with substituted pyridines 
































Fig. 2 — Electronic spectrum of Bis(m-ethylphenylxanthato)- 
bis(3-ethylpyridine)nickel(II) 
 




at 393.5 °C (found = 39.5%, calculated = 32.1%). A 
significant loss in mass of 57.2% was found at 512.5 °C 
(calculated =59%) due to loss of dithiocarbonate moiety. 
A gradual loss in weight on further heating leads to a 
stable sulphide, NiS as end product at 900 °C (Fig. 4). 
 
Powder X-Ray Diffraction 
The powder XRD of the adduct [Ni(m-
C2H5C6H4OCS2)2(2- chloropyridine)2] was done with 
the help of X- ray diffractometer (XPERT-PRO) with 
Cu as anode material, Kα (Ǻ) =1.5406 and the 
generator settings 40 mA, 45 kV.The diffraction 
pattern was recorded between 2θ ranging from 10° to 
90°. The recorded PXRD pattern of Cu(II) complex is 
shown in Fig. 5. The XRD pattern of the complex 
showed maximum intensity peak at 31.682 (2θ) which 
corresponds to the interplanar spacing (d) = 2.821 Å. 
The PXRD peak list of the complex along with the 
corresponding full width at half maximum (FWHM), 
relative intensities and d-spacing are given in Table 5. 
The peaks in the diffraction pattern reveal that  
the   complex  is  crystalline  in  nature.  The  Scherrer 
equation in X-ray diffraction and crystallography 
relates the size of particles or crystallites in a solid  to  
 
 









Fig. 3 — Mass spectrum of Bis(m-ethylphenylxanthato)bis(2-chloropyridine)nickel(II) 
 




the broadening of a peak in a diffraction pattern
35,36
. 
The Debye-Scherrer equation is D = kλ/β cos θ, 
where β = full width at half maximum height 
(0.001657 radians), k = constant taken as 0.9,  
λ = wavelength of X-ray radiation (Cu Kα =1.5406 
Ǻ), D = size of crystallite, θ = angle of diffraction 
(31.6825°). The crystallite size of the Ni(II) complex 
with 2-chloropyridine was found to be 86.9 nm. 
 
Field emission scanning electron microscope: 
FESEM of one of the adducts at different 
magnifications was done which clearly showed the 
homogeneous appearance of the microcrystals. These 
are irregular granular shaped in the form of clusters 





The antifungal data for Bipolaris maydisis reported 
in Table 6, according to which complex (a) showed 
large % inhibition in growth of fungus than  
complex (b) and (c). The antifungal results of 
Rhizoctonia solani are given in Table 7, which 
showed that complex (c) has high antifungal activity 
in comparison to (a) and (b). Therefore, the fungal 
colony diameter decreased, on increasing the complex 
concentration, which means percent inhibition of 
fungus increases. This enhanced activity is due to the 
reason that metal complexes diffused through the cell 
membrane, disturbed the respiration process of the 
cell and blocked the formation of proteins that 
inhibited the fungal growth. This can be more clearly 






The results regarding the in vitro cytotoxic effect of 
nickel(II) complexes against various human cancer 
cell lines are given in Table 8. The complex No. 1 
showed striking observations as the complex 
suppressed the proliferation of five tested human 
cancer cell lines in the range of 70-99%. Maximum 
growth inhibition i.e., 99% was observed against  
PC-3, a cancer cell line from prostate origin. The 
complex showed 98% growth inhibition against colon 
cancer cell line (HCT-116) and 97% growth inhibition 
against lung cancer cell line (A-549). 84% and 70% 
growth inhibition was  again  observed  against  colon  
Table 5 — PXRD data of adduct Bis(m-ethylphenyldithiocarbonato)bis(2-chloropyridine)nickel(II) 
Position [°2θ] FWHM Total [°2θ] d-spacing [Å] Rel. Int. [%] Area [cts*°2θ] 
18.7638 0.1802 4.72534 11.32 59.42 
27.3513 0.0714 3.25811 5.99 8.27 
31.6825 0.0950 2.82189 100.00 197.46 
45.4242 0.0893 1.99507 70.07 161.29 
56.4479 0.0950 1.62882 19.25 42.03 
62.0836 0.0340 1.49380 5.88 3.87 
75.2765 0.1369 1.26139 13.00 39.34 




Fig. 6 — FESEM images of nickel(II) complex of m-ethylphenylxanthate with 2-ethylpyridine 
 





Table 6 — In vitro antifungal activity of complexes of bis(m-ethylphenylxanthato)nickel(II) with nitrogen donors against Bipolaris maydis 
S. No. Name of the adduct Concentration 
(ppm) 
Colony diameter (T) 
(mm) 
% inhibition 





































































Table 7 — In vitro antifungal activity of complexes of bis(m-ethylphenylxanthato)nickel(II) with nitrogen donors against Rhizoctonia solani 
S. No. Name of the adduct  Concentrati
on (ppm) 
Colony diameter (T) 
(mm) 
% inhibition 






































































Table 8 — Growth inhibitory effect of Nickel(II)xanthate complexes along with positive controls against human cancer cell lines 
S. No. Nickel (II) complexes of  
m-ethylphenylxanthate 
with substituted pyridines 
Conc. 
(µg/mL) 
Human cancer cell lines from six  
different tissues 
Breast Colon Colon Colon Lung Ovary Prostate 
MCF-7 HT-29 HCT-116 SW-620 A-549 OVCAR-5 PC-3 








100 11 70 98 84 97 07 99 
[Ni(m-C2H5C6H4OCS2)2 
(3-C7H9N)2] 
100 19 50 09 52 74 11 00 
[Ni(m-C2H5C6H4OCS2)2 
(4-C7H9N)2] 
100 22 56 12 61 52 34 00 
Positive controls (standard drugs) Conc. (µM) Growth inhibition (%) 
5-Fluorouracil 20 - 72 65 68 - - - 
Mitomycin-C 1 - - - - - - 69 
Paclitaxel 1 77 - - - 71 84 - 
Growth inhibition of 50% or more has been indicated in bold numbers 
Mark (-) indicates that particular human cancer cell line was not treated with that particular positive control 
 






cancer cell lines namely SW-620 and HT-29, 
respectively. The Complex No. 2 was found active 
against lung cancer cell line (A-549, GI 74%) and 
colon cancer cell lines (HT-29, GI 52% and SW-620, 
GI 50%). Similarly, the Complex No. 3 showed  
in vitro cytotoxic effect against lung cancer cell line 
(A-549) and growth inhibition was 52%. The complex 
suppressed 61% and 56% proliferation of colon 
cancer cells - SW-620 and HT-29, respectively. 
 
Conclusions 
To conclude, the study confirms the formation of 
nickel(II)xanthate adducts with nitrogen donor ligands 
as indicated from elemental analysis, molar 
measurements, magnetic measurements, spectral 
analysis, powder XRD, FESEM and TGA. So, it is 
proposed that Ni(II) ion has a distorted octahedral 
coordination of ligands around it. The complexes 
show antifungal activities. The in vitro cytotoxic 
effect of these nickel(II) complexes against various 
human cancer cell lines were studied. 
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